These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21515841)

  • 21. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.
    Truyen I; De Grijse J; Weets I; Kaufman L; Pipeleers L; Nanos N; Decochez K; Hilbrands R; Kaufman JM; Keymeulen B; Mathieu C; Van Gaal L; Pipeleers DG; Gorus FK;
    Clin Exp Immunol; 2007 Aug; 149(2):243-50. PubMed ID: 17521324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
    Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
    J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years.
    Till AM; Kenk H; Rjasanowski I; Wassmuth R; Walschus U; Kerner W; Schlosser M
    Diabet Med; 2015 Aug; 32(8):1008-16. PubMed ID: 25523979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
    Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
    Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Ilonen J; Tuomilehto J; Akerblom HK; Knip M
    Diabetes; 2000 Jan; 49(1):48-58. PubMed ID: 10615949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from type 1 diabetes.
    Seissler J; Eikamp K; Schott M; Scherbaum WA;
    Horm Metab Res; 2002 Apr; 34(4):186-91. PubMed ID: 11987027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
    Komulainen J; Kulmala P; Savola K; Lounamaa R; Ilonen J; Reijonen H; Knip M; Akerblom HK
    Diabetes Care; 1999 Dec; 22(12):1950-5. PubMed ID: 10587824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of subclass distribution of insulin antibody with glucose control in insulin-treated type 2 diabetes mellitus: a retrospective observational study.
    Chen S; Chen H; Jiang Y; Zheng X; Zhang M; Yang T; Gu Y
    Front Endocrinol (Lausanne); 2023; 14():1141414. PubMed ID: 37143729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
    Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for future prevention studies.
    Van der Auwera BJ; Schuit FC; Weets I; Ivens A; Van Autreve JE; Gorus FK;
    Hum Immunol; 2002 Jan; 63(1):40-50. PubMed ID: 11916169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.
    Kukko M; Virtanen SM; Toivonen A; Simell S; Korhonen S; Ilonen J; Simel O; Knip M
    Diabetes Care; 2004 Mar; 27(3):676-81. PubMed ID: 14988284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes.
    Hoppu S; Härkönen T; Ronkainen MS; Akerblom HK; Knip M;
    J Autoimmun; 2004 Dec; 23(4):361-70. PubMed ID: 15571930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of type 1A diabetes.
    Eisenbarth GS; Jeffrey J
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):146-55. PubMed ID: 18438525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.
    Kimpimäki T; Kupila A; Hämäläinen AM; Kukko M; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4782-8. PubMed ID: 11600541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.